CN Stock MarketDetailed Quotes

003020 Hefei Lifeon Pharmaceutical

Watchlist
  • 19.56
  • -0.34-1.71%
Market Closed Dec 13 15:00 CST
3.75BMarket Cap21.49P/E (TTM)

Hefei Lifeon Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-26.20%1.13B
-39.32%769.33M
-58.90%333.62M
-26.31%1.9B
-19.52%1.52B
3.14%1.27B
29.14%811.82M
13.46%2.58B
13.77%1.89B
14.47%1.23B
Operating revenue
-26.20%1.13B
-39.32%769.33M
-58.90%333.62M
-26.31%1.9B
-19.52%1.52B
3.14%1.27B
29.14%811.82M
13.46%2.58B
13.77%1.89B
14.47%1.23B
Other operating revenue
----
92.44%11.77M
----
60.75%14.25M
----
75.17%6.11M
----
-24.67%8.86M
----
-38.67%3.49M
Total operating cost
-26.27%1B
-39.88%682.32M
-57.86%307.76M
-29.21%1.68B
-21.69%1.36B
1.23%1.13B
27.21%730.37M
13.36%2.38B
13.27%1.73B
13.92%1.12B
Operating cost
-58.50%338.42M
-69.65%219.06M
-79.93%103.4M
-42.90%922.2M
-29.85%815.4M
-3.32%721.72M
34.70%515.2M
18.23%1.62B
16.90%1.16B
16.79%746.53M
Operating tax surcharges
30.15%16.66M
16.91%11.67M
-15.14%4.8M
14.90%18.34M
6.89%12.8M
25.29%9.98M
32.29%5.66M
-1.88%15.96M
5.00%11.98M
13.33%7.97M
Operating expense
23.87%528.54M
11.67%370.54M
-13.61%158.41M
-2.91%598.45M
-8.77%426.7M
7.20%331.81M
12.82%183.37M
1.84%616.39M
3.69%467.73M
7.07%309.51M
Administration expense
37.25%63.91M
44.25%44.82M
19.01%18.05M
4.76%61.96M
17.64%46.56M
20.82%31.07M
29.98%15.16M
31.83%59.14M
22.94%39.58M
24.04%25.72M
Financial expense
90.11%-372.94K
78.70%-510.91K
71.63%-440.98K
7.13%-3.29M
-916.36%-3.77M
-1,082.64%-2.4M
-5,121.28%-1.55M
-121.63%-3.55M
71.49%-371.19K
124.66%244.06K
-Interest expense (Financial expense)
73.96%926.62K
-33.14%832.41K
106.40%230.38K
43.93%1.28M
254.87%532.67K
93.44%1.25M
-83.76%111.61K
-34.52%890.23K
-16.30%150.1K
-15.21%643.66K
-Interest Income (Financial expense)
62.01%-1.67M
62.94%-1.37M
45.08%-855.22K
-5.90%-4.65M
-155.71%-4.39M
-134.75%-3.7M
-84.13%-1.56M
-31.24%-4.39M
32.57%-1.72M
18.72%-1.57M
Research and development
-10.22%53.81M
-14.17%36.73M
87.78%23.55M
15.11%84.96M
14.40%59.93M
37.26%42.8M
-5.00%12.54M
12.06%73.8M
22.13%52.39M
7.18%31.18M
Credit Impairment Loss
48.83%-1.97M
63.04%-2.13M
49.93%-790.34K
-780.30%-2.11M
-137.21%-3.85M
-339.74%-5.76M
-15.59%-1.58M
-115.20%-239.15K
23.55%-1.62M
22.67%-1.31M
Asset Impairment Loss
-64.63%-9.05M
-202.75%-9.55M
14.19%-2.07M
-143.32%-9.2M
-57.11%-5.5M
-21.54%-3.16M
-251.81%-2.41M
-34.48%-3.78M
-142.42%-3.5M
-258.75%-2.6M
Other net revenue
-69.70%7.41M
-98.71%183.86K
189.80%3.16M
-1.14%37.09M
-28.66%24.45M
257.67%14.22M
-922.35%-3.52M
135.81%37.52M
398.37%34.27M
23.15%3.98M
Fair value change income
-47.78%1.25M
5.67%1.46M
25,297.63%972.79K
926.44%315.52K
188.05%2.39M
-43.16%1.38M
67.86%-3.86K
-256.00%-38.18K
-33.74%829.19K
86.35%2.43M
Invest income
-67.18%9.03M
-73.39%5.27M
1,038.88%3.43M
-14.88%27.49M
-10.12%27.5M
2,776.60%19.79M
-223.33%-365.67K
187.41%32.29M
379.18%30.6M
-127.09%-739.48K
-Including: Investment income associates
----
----
392.73%1.94M
126.44%1.06M
----
----
53.97%-662.67K
-21.23%-4M
----
----
Asset deal income
--92.97K
2,621.34%96.4K
----
----
----
99.84%-3.82K
79.37%-1.36K
-8,364.51%-2.54M
-10,261.63%-2.51M
-9,246.92%-2.41M
Other revenue
106.33%8.07M
155.81%5.05M
91.41%1.61M
74.10%20.59M
-62.67%3.91M
-77.07%1.97M
-67.70%843.37K
54.85%11.83M
269.92%10.47M
424.29%8.6M
Operating profit
-31.24%131.56M
-40.69%87.2M
-62.76%29.02M
6.34%255.27M
-1.74%191.33M
31.22%147.02M
41.89%77.92M
24.73%240.05M
37.96%194.72M
20.62%112.05M
Add:Non operating Income
79.58%456.2K
107.19%395.08K
113.46%237.28K
641.47%3.15M
-29.88%254.04K
-15.45%190.69K
21.73%111.16K
-86.39%424.2K
-88.45%362.29K
-92.59%225.53K
Less:Non operating expense
3.21%699.74K
15.28%647.46K
25,623.96%244.05K
52.30%998.83K
44.83%678K
106.28%561.61K
-99.46%948.74
-10.90%655.81K
-1.99%468.13K
-20.18%272.26K
Total profit
-31.21%131.32M
-40.71%86.94M
-62.83%29.01M
7.34%257.42M
-1.90%190.91M
30.94%146.65M
42.32%78.03M
23.09%239.82M
35.34%194.61M
17.16%112M
Less:Income tax cost
-13.35%15.66M
-29.44%10.95M
-86.94%1.55M
-23.03%23.53M
-24.87%18.08M
12.23%15.52M
54.36%11.89M
35.24%30.57M
30.38%24.06M
15.17%13.83M
Net profit
-33.08%115.66M
-42.05%75.99M
-58.49%27.46M
11.77%233.88M
1.34%172.83M
33.57%131.13M
40.35%66.14M
21.50%209.25M
36.07%170.55M
17.45%98.17M
Net profit from continuing operation
-33.08%115.66M
-42.05%75.99M
-58.49%27.46M
11.77%233.88M
1.34%172.83M
33.57%131.13M
40.35%66.14M
21.50%209.25M
36.07%170.55M
17.45%98.17M
Less:Minority Profit
-328.33%-3.32M
---1.44M
---2.92M
--7.21M
--1.46M
----
----
----
----
----
Net profit of parent company owners
-30.57%118.98M
-40.95%77.43M
-54.08%30.37M
8.33%226.67M
0.48%171.38M
33.57%131.13M
40.35%66.14M
21.50%209.25M
36.07%170.55M
17.45%98.17M
Earning per share
Basic earning per share
-30.77%0.63
-41.18%0.4
-53.66%0.19
6.77%1.42
-16.51%0.91
9.68%0.68
7.89%0.41
-6.99%1.33
4.73%1.09
-10.14%0.62
Diluted earning per share
-30.77%0.63
-41.18%0.4
-53.66%0.19
6.77%1.42
-16.51%0.91
9.68%0.68
7.89%0.41
-6.99%1.33
4.73%1.09
-10.14%0.62
Other composite income
Total composite income
-33.08%115.66M
-42.05%75.99M
-58.49%27.46M
11.77%233.88M
1.34%172.83M
33.57%131.13M
40.35%66.14M
21.50%209.25M
36.07%170.55M
17.45%98.17M
Total composite income of parent company owners
-30.57%118.98M
-40.95%77.43M
-54.08%30.37M
8.33%226.67M
0.48%171.38M
33.57%131.13M
40.35%66.14M
21.50%209.25M
36.07%170.55M
17.45%98.17M
Total composite income of minority owners
-328.33%-3.32M
---1.44M
---2.92M
--7.21M
--1.46M
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -26.20%1.13B-39.32%769.33M-58.90%333.62M-26.31%1.9B-19.52%1.52B3.14%1.27B29.14%811.82M13.46%2.58B13.77%1.89B14.47%1.23B
Operating revenue -26.20%1.13B-39.32%769.33M-58.90%333.62M-26.31%1.9B-19.52%1.52B3.14%1.27B29.14%811.82M13.46%2.58B13.77%1.89B14.47%1.23B
Other operating revenue ----92.44%11.77M----60.75%14.25M----75.17%6.11M-----24.67%8.86M-----38.67%3.49M
Total operating cost -26.27%1B-39.88%682.32M-57.86%307.76M-29.21%1.68B-21.69%1.36B1.23%1.13B27.21%730.37M13.36%2.38B13.27%1.73B13.92%1.12B
Operating cost -58.50%338.42M-69.65%219.06M-79.93%103.4M-42.90%922.2M-29.85%815.4M-3.32%721.72M34.70%515.2M18.23%1.62B16.90%1.16B16.79%746.53M
Operating tax surcharges 30.15%16.66M16.91%11.67M-15.14%4.8M14.90%18.34M6.89%12.8M25.29%9.98M32.29%5.66M-1.88%15.96M5.00%11.98M13.33%7.97M
Operating expense 23.87%528.54M11.67%370.54M-13.61%158.41M-2.91%598.45M-8.77%426.7M7.20%331.81M12.82%183.37M1.84%616.39M3.69%467.73M7.07%309.51M
Administration expense 37.25%63.91M44.25%44.82M19.01%18.05M4.76%61.96M17.64%46.56M20.82%31.07M29.98%15.16M31.83%59.14M22.94%39.58M24.04%25.72M
Financial expense 90.11%-372.94K78.70%-510.91K71.63%-440.98K7.13%-3.29M-916.36%-3.77M-1,082.64%-2.4M-5,121.28%-1.55M-121.63%-3.55M71.49%-371.19K124.66%244.06K
-Interest expense (Financial expense) 73.96%926.62K-33.14%832.41K106.40%230.38K43.93%1.28M254.87%532.67K93.44%1.25M-83.76%111.61K-34.52%890.23K-16.30%150.1K-15.21%643.66K
-Interest Income (Financial expense) 62.01%-1.67M62.94%-1.37M45.08%-855.22K-5.90%-4.65M-155.71%-4.39M-134.75%-3.7M-84.13%-1.56M-31.24%-4.39M32.57%-1.72M18.72%-1.57M
Research and development -10.22%53.81M-14.17%36.73M87.78%23.55M15.11%84.96M14.40%59.93M37.26%42.8M-5.00%12.54M12.06%73.8M22.13%52.39M7.18%31.18M
Credit Impairment Loss 48.83%-1.97M63.04%-2.13M49.93%-790.34K-780.30%-2.11M-137.21%-3.85M-339.74%-5.76M-15.59%-1.58M-115.20%-239.15K23.55%-1.62M22.67%-1.31M
Asset Impairment Loss -64.63%-9.05M-202.75%-9.55M14.19%-2.07M-143.32%-9.2M-57.11%-5.5M-21.54%-3.16M-251.81%-2.41M-34.48%-3.78M-142.42%-3.5M-258.75%-2.6M
Other net revenue -69.70%7.41M-98.71%183.86K189.80%3.16M-1.14%37.09M-28.66%24.45M257.67%14.22M-922.35%-3.52M135.81%37.52M398.37%34.27M23.15%3.98M
Fair value change income -47.78%1.25M5.67%1.46M25,297.63%972.79K926.44%315.52K188.05%2.39M-43.16%1.38M67.86%-3.86K-256.00%-38.18K-33.74%829.19K86.35%2.43M
Invest income -67.18%9.03M-73.39%5.27M1,038.88%3.43M-14.88%27.49M-10.12%27.5M2,776.60%19.79M-223.33%-365.67K187.41%32.29M379.18%30.6M-127.09%-739.48K
-Including: Investment income associates --------392.73%1.94M126.44%1.06M--------53.97%-662.67K-21.23%-4M--------
Asset deal income --92.97K2,621.34%96.4K------------99.84%-3.82K79.37%-1.36K-8,364.51%-2.54M-10,261.63%-2.51M-9,246.92%-2.41M
Other revenue 106.33%8.07M155.81%5.05M91.41%1.61M74.10%20.59M-62.67%3.91M-77.07%1.97M-67.70%843.37K54.85%11.83M269.92%10.47M424.29%8.6M
Operating profit -31.24%131.56M-40.69%87.2M-62.76%29.02M6.34%255.27M-1.74%191.33M31.22%147.02M41.89%77.92M24.73%240.05M37.96%194.72M20.62%112.05M
Add:Non operating Income 79.58%456.2K107.19%395.08K113.46%237.28K641.47%3.15M-29.88%254.04K-15.45%190.69K21.73%111.16K-86.39%424.2K-88.45%362.29K-92.59%225.53K
Less:Non operating expense 3.21%699.74K15.28%647.46K25,623.96%244.05K52.30%998.83K44.83%678K106.28%561.61K-99.46%948.74-10.90%655.81K-1.99%468.13K-20.18%272.26K
Total profit -31.21%131.32M-40.71%86.94M-62.83%29.01M7.34%257.42M-1.90%190.91M30.94%146.65M42.32%78.03M23.09%239.82M35.34%194.61M17.16%112M
Less:Income tax cost -13.35%15.66M-29.44%10.95M-86.94%1.55M-23.03%23.53M-24.87%18.08M12.23%15.52M54.36%11.89M35.24%30.57M30.38%24.06M15.17%13.83M
Net profit -33.08%115.66M-42.05%75.99M-58.49%27.46M11.77%233.88M1.34%172.83M33.57%131.13M40.35%66.14M21.50%209.25M36.07%170.55M17.45%98.17M
Net profit from continuing operation -33.08%115.66M-42.05%75.99M-58.49%27.46M11.77%233.88M1.34%172.83M33.57%131.13M40.35%66.14M21.50%209.25M36.07%170.55M17.45%98.17M
Less:Minority Profit -328.33%-3.32M---1.44M---2.92M--7.21M--1.46M--------------------
Net profit of parent company owners -30.57%118.98M-40.95%77.43M-54.08%30.37M8.33%226.67M0.48%171.38M33.57%131.13M40.35%66.14M21.50%209.25M36.07%170.55M17.45%98.17M
Earning per share
Basic earning per share -30.77%0.63-41.18%0.4-53.66%0.196.77%1.42-16.51%0.919.68%0.687.89%0.41-6.99%1.334.73%1.09-10.14%0.62
Diluted earning per share -30.77%0.63-41.18%0.4-53.66%0.196.77%1.42-16.51%0.919.68%0.687.89%0.41-6.99%1.334.73%1.09-10.14%0.62
Other composite income
Total composite income -33.08%115.66M-42.05%75.99M-58.49%27.46M11.77%233.88M1.34%172.83M33.57%131.13M40.35%66.14M21.50%209.25M36.07%170.55M17.45%98.17M
Total composite income of parent company owners -30.57%118.98M-40.95%77.43M-54.08%30.37M8.33%226.67M0.48%171.38M33.57%131.13M40.35%66.14M21.50%209.25M36.07%170.55M17.45%98.17M
Total composite income of minority owners -328.33%-3.32M---1.44M---2.92M--7.21M--1.46M--------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday-1.88%